Conditional transgene expression is a potentially useful approach to i
nvestigate complex biological systems in vivo. We recently demonstrate
d that tetracycline-responsive promoters could be employed to achieve
regulated, cardiac-specific expression of target genes in transgenic m
ice. To more fully define the quantitative and spatial parameters asso
ciated with tetracycline-regulated gene expression in the heart, we cr
ossed transgenic mice harboring either a firefly luciferase or a nucle
ar-localized bacterial lacZ target gene with strains expressing a tetr
acycline-controlled transactivator (tTA) under the regulatory control
of 2.9 kb of 5' flanking sequence from the rat alpha-myosin heavy chai
n gene. Luciferase activity was induced nearly 300-fold in the hearts
of binary-transgenic mice compared with mice carrying only the lucifer
ase reporter gene. No significant transactivation was observed in any
other tissues examined. Binary transgenics harboring the lacZ reporter
gene showed substantial beta-galactosidase activity throughout the he
art, but the response of individual cardiac myocytes was heterogeneous
. For both reporter genes, tetracycline treatment fully repressed tTA-
dependent transactivation. These data provide important insights into
the nature of studies that can be successfully addressed using the tet
racycline-regulated gene expression system in the heart.